ClotProtect Therapeutics Limited
ClotProtect Therapeutics Limited is a UK-based therapeutics spin-out from the University of Leeds, pioneering a first-in-class small molecule anti-fibrinolytic to address acute bleeding. The company is led by a team of world-leading scientific experts, clinical key opinion leaders, and experienced pharma industry professionals. Their mission is to transform the treatment of acute haemorrhage and traumatic bleeding, aiming to save lives with innovative, more effective therapies. ClotProtect is currently in preclinical development, working towards identifying a clinical drug candidate that offers superior efficacy and safety compared to current standards of care.
Industries
N/A
Nr. of Employees
small (1-50)
ClotProtect Therapeutics Limited
Nexus, Discovery Way, Leeds, United Kingdom, LS2 3AA
Products
Preclinical small-molecule plasmin inhibitor (development candidate)
A first-in-class small-molecule anti-fibrinolytic designed to directly inhibit plasmin, with preclinical data indicating prevention of clot breakdown and comparative efficacy versus the current standard anti-fibrinolytic.
Preclinical small-molecule plasmin inhibitor (development candidate)
A first-in-class small-molecule anti-fibrinolytic designed to directly inhibit plasmin, with preclinical data indicating prevention of clot breakdown and comparative efficacy versus the current standard anti-fibrinolytic.
Services
Engagements with external partners for research collaboration, development partnerships and investment discussions related to anti-fibrinolytic drug development.
Engagements with external partners for research collaboration, development partnerships and investment discussions related to anti-fibrinolytic drug development.
Expertise Areas
- Anti-fibrinolytic drug development
- Small-molecule therapeutics discovery
- Preclinical pharmacology and validation
- Mechanistic studies of fibrinolysis
Key Technologies
- Small-molecule therapeutics
- Direct plasmin inhibition mechanism studies
- In vitro and in vivo fibrinolysis models
- Pharmacodynamics and clot-stability assays
News & Updates
Example placeholder post. No substantive article content provided.
Example placeholder post. No substantive article content provided.